Research LetterIn-Press PreviewInfectious diseasePublic Health
Open Access | 
10.1172/jci.insight.208557
The monoclonal antibody VYD2311 potently neutralizes dominant and emerging SARS-CoV-2 variants
Ian A. Mellis,1 Madeline Wu,1 Kristin Daniel,1 Hsiang Hong,1 Yicheng Guo,1 and David D. Ho1
1Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, United States of America
Find articles by Mellis, I. in: PubMed | Google Scholar
1Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, United States of America
Find articles by Wu, M. in: PubMed | Google Scholar
1Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, United States of America
Find articles by Daniel, K. in: PubMed | Google Scholar
1Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, United States of America
Find articles by Hong, H. in: PubMed | Google Scholar
1Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, United States of America
Find articles by Guo, Y. in: PubMed | Google Scholar
1Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, United States of America
Find articles by Ho, D. in: PubMed | Google Scholar
Published August 11, 2026 - More info
Copyright © 2026, Mellis et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
